Beijing Balance Medical Technology Co (688198.SS) Stock Price

Beijing Balance Medical Technology Co Price

CLOSED
67.50
​
Market closed

Revenue has compounded at 25.8% per year over the past 9 years to 620.15 M CNY. Earnings per share have grown at 22.5% per year over the last 9 years. Beijing Balance Medical Technology Co's net margin stands at 31.2%, up from 20.3% several years earlier. Beijing Balance Medical Technology Co currently offers a dividend yield of about 1.19%. The payout ratio is around 57% of earnings. The dividend has grown at 41.1% per year over the past 5 years.

Beijing Balance Medical Technology Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Balance Medical Technology Co business model & stock analysis

Beijing Balance Medical Technology Co., Ltd. generates revenue through the manufacture and sale of biotechnology products across three key therapeutic areas. The company's heart valve replacement and repair segment offers artificial biological heart valves and valve forming rings, while its congenital heart disease interventional therapy line includes cardiothoracic surgical biological patches, outflow tract single valve patches, and atrial defect occluders. The surgical soft tissue repair division provides neurosurgical biological patches and biological hernia patches. All products are sold primarily within China's domestic market to hospitals and medical institutions seeking advanced cardiovascular and surgical solutions. The firm's product portfolio targets medical professionals specializing in cardiac surgery, congenital heart defect correction, and soft tissue repair procedures. Hospitals and healthcare providers in China purchase these biotechnology solutions for patient treatments, with the domestic market serving as the primary sales channel. The company's focus on specialized medical devices for heart valve procedures, congenital heart conditions, and surgical repair applications drives its revenue streams. Beijing Balance Medical Technology's business model centers on developing and distributing high-precision medical devices tailored to specific surgical needs. The domestic Chinese healthcare system represents the main customer segment, with hospitals and clinics purchasing the company's products for use in cardiac surgeries, congenital heart defect corrections, and soft tissue repair operations. The company's product range directly supports medical procedures requiring biological heart valves, congenital heart disease interventions, and surgical tissue repair solutions.

Frequently asked questions about Beijing Balance Medical Technology Co

5 analysts currently rate the Beijing Balance Medical Technology Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Beijing Balance Medical Technology Co to generate revenue of 845.00 M CNY and earnings per share of 1.53 CNY.

Converted at the current exchange rate, the Beijing Balance Medical Technology Co share trades at 9.21 EUR (67.50 CNY).

The expected revenue of Beijing Balance Medical Technology Co is 845.00 M CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Beijing Balance Medical Technology Co is 210.76 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Beijing Balance Medical Technology Co is currently 44.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Beijing Balance Medical Technology Co stock.

The price-to-sales ratio (P/S) of Beijing Balance Medical Technology Co is currently 10.98. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Beijing Balance Medical Technology Co stock.

The Eulerpool Quality Score for Beijing Balance Medical Technology Co is 5/10.

The ISIN of Beijing Balance Medical Technology Co is CNE100005X15. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Beijing Balance Medical Technology Co is 688198.SS. The ticker symbol is used to trade Beijing Balance Medical Technology Co shares on the stock exchange.

Fair ValueTerminal
71.55 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
1.75 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Dec 9, 2019
ISIN
CNE100005X15
Cusip
Y077F2100
Market capitalization
9.30 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
44.12
P/Ee 2027
29.22
P/Se
10.98
EV/EBIT
45.18
P/B Ratio
7.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
14.59 %
Dividend
Dividend yield
1.19 %
Est. Dividend Yield
1.19 %
Payout Ratio
56.78 %
Dividend growth Ø5Y
9.86 %
Dividend payments per year
1
Dividend paid since
6 years
Dividend not reduced since
6 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Nov 19, 2026, 3:41 AM

Beijing Balance Medical Technology Co Peer Group

Beijing Balance Medical Technology Co FIGI

688198:CH · BBG00NWP3WJ4688198:CG · BBG00NWP3WK2688198:C1 · BBG01FRBBQB9